ADAR1 Capital Management »

Zai Lab shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Zai Lab (ZLAB) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Zai Lab

Tip: Access up to 7 years of quarterly data

All positions including Zai Lab held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zai Lab by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $352k 22k 16.02
2023-12-31 $547k 20k 27.33

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Zai Lab

Henderson Group
Capital World Investors
Viking Global Investors
T. Rowe Price Associates
Bamco
Woodline Partners
Citadel Advisors
Rock Springs Capital Management
ClearBridge Advisors
BlackRock
BlackRock
Connor, Clark & Lunn Investment Management
Morgan Stanley
Allianz Asset Management
CAM Group Holding A/S

View all funds holding Zai Lab